Campbell & CO Investment Adviser LLC Medpace Holdings, Inc. Transaction History

Campbell & CO Investment Adviser LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$284.87 - $413.31 $2.64 Million - $3.83 Million	-9,264 Reduced 52.3%	8,448 $3.41 Million
Q4 2023 Feb 13, 2024	BUY	$227.52 - $312.68 $4.03 Million - $5.54 Million	17,712 New	17,712 $5.43 Million
Q2 2023 Aug 11, 2023	BUY	$187.26 - $240.17 $123,217 - $158,031	658 Added 31.76%	2,730 $655,000
Q1 2023 May 11, 2023	SELL	$174.31 - $239.52 $42,008 - $57,724	-241 Reduced 10.42%	2,072 $389,000
Q4 2022 Feb 14, 2023	BUY	$153.06 - $226.57 $354,027 - $524,056	2,313 New	2,313 $491,000

654

25.6M

38.7K

79.5K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.3B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.